Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature.

Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature. Abstract Text:

Tumor lysis syndrome (TLS) is a critical illness with few treatment options. This report describes the clinical course of a patient with non-Hodgkin's lymphoma, who developed TLS and required renal replacement therapy. Institution of the standard therapeutic approach, intermittent hemodialysis, was not possible because of persistent hypotension. Instead, the patient was treated with a short course of continuous arteriovenous hemofiltration (CAVH) and conventional continuous arteriovenous hemodialysis (CAVHD) with dialysate flow rate of 1 L/h), which resulted in effective control of serum uric acid, potassium, urea nitrogen, phosphorus, and extracellular fluid volume. This case is in distinction to a previous report of TLS treatment with CAVHD using 4 L/h dialysate flow rate. We conclude that continuous renal replacement therapies with standard dialysate flow rates and replacement volumes should be considered for the treatment of TLS, particulary if the syndrome is accompanied by hypotension.

Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature. Journal Published:

PUBLICATION TYPE: Review

Journal: Renal failure

VOLUME: 20

Page Numbers: 635-44

Journal Abbreviation: Ren Fail

ISSN: 0886-022X

DAY: 21

MONTH: Jul

YEAR: 1998

Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature. Information

Number of References: 32

LANGUAGE: eng

NlmUniqueID: 8701128

Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature. Keywords Mesh Terms:

KEYWORDS: Tumor Lysis Syndrome

MESH TERMS: therapy

Chemical & Substance for Abstract: Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature.

AFFILIATION: Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Country: UNITED STATES

AGENCY: United States NIDDK

GRANT: DK-38558

ACRONYM:

MEDLINETA: Ren Fail

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature Related Publications

• Aminimidesi I. Antimicrobial effect of some long chain fatty acid derivatives.
• Approaches to understanding susceptibility to nephropathy: From genetics to genomics.
• Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature.
• Mining the genome for susceptibility to diabetic nephropathy: the role of large-scale studies and consortia.